RxDoctor Payments Data

Jessica Shellock, MD

Orthopaedic Surgery of the Spine · Plano, TXNPI 1700975398

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $227,197 of the $263,944 with a category attached, or 86.1%. 14 manufacturers reported payments, led by Centinel Spine, LLC at 44.2% of the total. Reporting peaked in 2021 at $60,737 and has fallen 78.5% since, to $13,032 in 2025.

$263,944in general payments, 2019–2025

Across 296 payments — averaging $891.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Centinel Spine, LLC$117K
  • Seaspine Orthopedics Corporation$41K
  • Aesculap Implant Systems, LLC$36K
  • Orthofix Medical, Inc.$21K
  • Zimvie Inc.$16K
  • Axis Spine Technologies Inc.$16K
  • plus $16K from 8 others
$58,468in research payments, 2019–2025

Across 25 payments — averaging $2338.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Centinel Spine, LLC$58K

What the payments were for

  • Consulting fees$227,19786%
  • Speaking & faculty fees$12,5465%
  • Travel & lodging$14,2395%
  • Food & beverage$9,9624%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$263,944 in reported general payments places this provider in the 85th percentile of 207 orthopaedic surgery of the spine providers in Texas.

See all orthopaedic surgery of the spine providers in Texas

Medicare billing

Part B allowed, 2024
$58,445
Medicare patients
176
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin27$175
Methylprednisolone13$87
Cyclobenzaprine Hcl17$81
Meloxicam17$40

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →